Complesso Ospedaliero S. Giovanni Addolorata

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Acute lymphoblastic leukaemia1 trial
• Chronic myeloid leukaemia1 trial

Phase

• Phase 21 trial

Status

• Completed2 trials

Lead sponsor

• Gruppo Italiano Malattie EMatologiche dell'Adulto2 trials

Closed trials

• Completed

  Sequential Chemotherapy and Blinatumomab to Improve MRD Response and Survival in Acute Lymphoblastic Leukemia

  NCT03367299· Phase 2· Gruppo Italiano Malattie EMatologiche dell'Adulto· Source

• Completed

  Front-line Nilotinib Treatment of BCR-ABL+ Chronic Myeloid Leukaemia in Chronic Phase

  NCT01699217· Gruppo Italiano Malattie EMatologiche dell'Adulto· Source